Index of reports
> Cases with Pierre Robin Syndrome (11)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Nitrofurantoin where reactions include pierre robin syndrome. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Nitrofurantoin side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-14
Patient: male
Reactions: Cytogenetic Abnormality, Dysmorphism, Maternal Drugs Affecting Foetus, Glaucoma, Pneumonia Aspiration, Micrognathia, Pierre Robin Syndrome, Caesarean Section, Cleft Palate, Developmental Delay, Respiratory Disorder Neonatal, Laryngomalacia, Gastrooesophageal Reflux Disease, Myopia, Ear Infection, Torticollis, Deafness Congenital, Respiratory Distress, Hyperbilirubinaemia Neonatal, Craniosynostosis, Bronchial Hyperreactivity, Respiratory Tract Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Codeine Phosphate, Guaifenesin (Cheracol / 00693301 / )
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Olopatadine Hydrochloride
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Nitrofurantoin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Cetirizine
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Azithromycin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Topiramate
Dosage: 50 mg (25 mg, 2 in 1 d), transplacental
Indication: Migraine
Start date: 2010-03-15
End date: 2010-04-15
Amoxicillin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Ibuprofen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Hydrocodone Bitartrate and Acetaminophen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Sumatriptan
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Fluticasone Propionate
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Cyclobenzaprine
Dosage: 30 mg (10 mg, 3 in 1 d), transplacental
Indication: Sciatic Nerve Injury
Naproxen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Prenatal Vitamins (Prenatal Viotamins / 01549301 / )
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Possible Nitrofurantoin side effects in male
Reported by a lawyer from United States on 2012-05-08
Patient: male
Reactions: Pneumonia Aspiration, Respiratory Disorder, Hyperbilirubinaemia, Glaucoma, Pneumonia, Deafness, Pierre Robin Syndrome, Ear Infection, Torticollis, Maternal Exposure Timing Unspecified, Cleft Palate, Body Dysmorphic Disorder, Craniosynostosis, Developmental Delay, Bronchial Hyperreactivity, Gastrooesophageal Reflux Disease
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cetirizine Hydrochloride
Dosage: unk
Start date: 2010-03-25
Amoxicillin
Dosage: unk
Start date: 2010-03-25
Topamax
Dosage: 25 mg four times a day for 1 week
Topamax
Dosage: 25 mg in the morning and 25 mg at night for 1 week
Nitrofurantoin
Dosage: unk
Naproxen
Dosage: unk
Start date: 2010-03-25
Sumitriptan Succinate
Dosage: unk
Start date: 2010-03-25
Topamax
Dosage: 25 mg two times a day
Indication: Migraine
Start date: 2010-03-15
End date: 2010-04-15
Flexeril
Dosage: 10 mg, 3x/day
Indication: Sciatic Nerve Injury
Multi-Vitamins
Dosage: unk
Fluticasone Propionate
Dosage: unk
Start date: 2010-03-25
Olopatadine HCL
Dosage: unk
Start date: 2010-03-25
Ibuprofen
Dosage: unk
Start date: 2010-03-25
Topamax
Dosage: 25 mg two times a day for 1 week
Cheracol / USA /
Dosage: unk
Start date: 2010-03-25
Vicodin
Dosage: unk
Start date: 2010-03-25
Azithromycin
Dosage: unk
Start date: 2010-03-25
Possible Nitrofurantoin side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-04
Patient: male
Reactions: Hyperbilirubinaemia, Maternal Drugs Affecting Foetus, Cytogenetic Abnormality, Glaucoma, Pierre Robin Syndrome, Deafness, Micrognathia, Body Dysmorphic Disorder, Cleft Palate, Caesarean Section, Developmental Delay, Cough, Dyspnoea, Chest Discomfort, Myopia, Craniosynostosis, Bronchial Hyperreactivity
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclobenzaprine
Dosage: 30 mg (10 mg, 3 in 1 d), transplacental
Indication: Sciatic Nerve Injury
Amoxicillin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Topiramate
Dosage: 50;100;1w mg (25 mg, 2 in 1 d), transplacental
Indication: Migraine
Naproxen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Sumatriptan
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Nitrofurantoin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Hydrocodone Bitartrate and Acetaminophen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Prenatal Vitamins (Prenatal Vitamins (01549301)
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Fluticasone Propionate
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Azithromycin
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Ibuprofen
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Cetirizine
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Codeine Phosphate, Guaifenesin (Cheracol / 00693301 / )
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Olopatadine Hydrochloride
Dosage: transplacental
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-25
Possible Nitrofurantoin side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-04
Patient: male
Reactions: Hyperbilirubinaemia, Maternal Drugs Affecting Foetus, Respiratory Disorder, Pneumonia Aspiration, Glaucoma, Pierre Robin Syndrome, Deafness, Torticollis, Body Dysmorphic Disorder, Craniosynostosis, Cleft Palate, Developmental Delay, Bronchial Hyperreactivity, Gastrooesophageal Reflux Disease
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Amoxicillin
Indication: Foetal Exposure During Pregnancy
Multi-Vitamins
Indication: Foetal Exposure During Pregnancy
Guaifenesin / Codeine
Indication: Foetal Exposure During Pregnancy
Ibuprofen
Indication: Foetal Exposure During Pregnancy
Sumatriptan Succinate
Indication: Foetal Exposure During Pregnancy
Cetirizine HCL
Indication: Foetal Exposure During Pregnancy
Fluticasone Propionate
Indication: Foetal Exposure During Pregnancy
Hydrocodone Bitartrate + Acetaminophen
Indication: Foetal Exposure During Pregnancy
Olopatadine HCL
Indication: Foetal Exposure During Pregnancy
Topamax
Indication: Foetal Exposure During Pregnancy
End date: 2010-11-01
Flexeril
Indication: Foetal Exposure During Pregnancy
Nitrofurantoin
Indication: Foetal Exposure During Pregnancy
Azithromycin
Indication: Foetal Exposure During Pregnancy
Naproxen
Indication: Foetal Exposure During Pregnancy
Possible Nitrofurantoin side effects in male
Reported by a lawyer from United States on 2012-05-01
Patient: male
Reactions: Pneumonia Aspiration, Glaucoma, Hyperbilirubinaemia, Cytogenetic Abnormality, Respiratory Disorder, Maternal Drugs Affecting Foetus, Deafness, Pierre Robin Syndrome, Caesarean Section, Cleft Palate, Body Dysmorphic Disorder, Respiratory Disorder Neonatal, Developmental Delay, Laryngomalacia, Gastrooesophageal Reflux Disease, Pneumonia, Myopia, Ear Infection, Torticollis, Maternal Exposure Timing Unspecified, Respiratory Distress, Hyperbilirubinaemia Neonatal, Craniosynostosis, Bronchial Hyperreactivity, Respiratory Tract Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Topamax
Dosage: 25 mg in the morning and 25 mg at night for 1 week
Topamax
Dosage: 25 mg two times a day for 1 week
Fluticasone Propionate
Dosage: unk
Start date: 2010-03-25
Olopatadine HCL
Dosage: unk
Start date: 2010-03-25
Azithromycin
Dosage: unk
Start date: 2010-03-25
Topamax
Dosage: 25 mg four times a day for 1 week
Cheracol / USA /
Dosage: unk
Start date: 2010-03-25
Flexeril
Dosage: 10 mg, 3x/day
Indication: Sciatic Nerve Injury
Ibuprofen
Dosage: unk
Start date: 2010-03-25
Topamax
Dosage: 25 mg two times a day
Indication: Migraine
Start date: 2010-03-15
End date: 2010-04-15
Nitrofurantoin
Dosage: unk
Multi-Vitamins
Dosage: unk
Vicodin
Dosage: unk
Start date: 2010-03-25
Naproxen
Dosage: unk
Start date: 2010-03-25
Cetirizine HCL
Dosage: unk
Start date: 2010-03-25
Amoxicillin
Dosage: unk
Start date: 2010-03-25
Sumatriptan Succinate
Dosage: unk
Start date: 2010-03-25
Possible Nitrofurantoin side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-27
Patient: male
Reactions: Respiratory Disorder, Pneumonia Aspiration, Hyperbilirubinaemia, Glaucoma, Deafness, Pierre Robin Syndrome, Craniosynostosis, Body Dysmorphic Disorder, Cleft Palate, Developmental Delay, Bronchial Hyperreactivity
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Nitrofurantoin
Indication: Foetal Exposure During Pregnancy
Topamax
Indication: Foetal Exposure During Pregnancy
End date: 2010-11-01
Flexeril
Indication: Foetal Exposure During Pregnancy
Cetirizine HCL
Indication: Foetal Exposure During Pregnancy
Amoxicillin
Indication: Foetal Exposure During Pregnancy
Sumatriptan Succinate
Indication: Foetal Exposure During Pregnancy
Guaifenesin / Codeine
Indication: Foetal Exposure During Pregnancy
Olopatadine HCL
Indication: Foetal Exposure During Pregnancy
Ibuprofen
Indication: Foetal Exposure During Pregnancy
Multi-Vitamins
Indication: Foetal Exposure During Pregnancy
Azithromycin
Indication: Foetal Exposure During Pregnancy
Fluticasone Propionate
Indication: Foetal Exposure During Pregnancy
Naproxen
Indication: Foetal Exposure During Pregnancy
Hydrocodone Bitartrate + Acetaminophen
Indication: Foetal Exposure During Pregnancy
Possible Nitrofurantoin side effects in male
Reported by a lawyer from United States on 2012-04-25
Patient: male
Reactions: Pneumonia, Glaucoma, Respiratory Disorder, Hyperbilirubinaemia, Ear Infection, Deafness, Pierre Robin Syndrome, Maternal Exposure Timing Unspecified, Cleft Palate, Craniosynostosis, Body Dysmorphic Disorder, Developmental Delay
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Olopatadine HCL
Dosage: unk
Start date: 2010-03-25
Ibuprofen
Dosage: unk
Start date: 2010-03-25
Flexeril
Dosage: 10 mg, 3x/day
Indication: Sciatic Nerve Injury
Sumatriptan Succinate
Dosage: unk
Start date: 2010-03-25
Topamax
Dosage: 25 mg two times a day
Indication: Migraine
Start date: 2010-03-15
End date: 2010-04-15
Topamax
Dosage: 25 mg in the morning and 25 mg at night for 1 week
Topamax
Dosage: 25 mg four times a day for 1 week
Nitrofurantoin
Dosage: unk
Multi-Vitamins
Dosage: unk
Cetirizine HCL
Dosage: unk
Start date: 2010-03-25
Topamax
Dosage: 25 mg two times a day for 1 week
Amoxicillin
Dosage: unk
Start date: 2010-03-25
Azithromycin
Dosage: unk
Start date: 2010-03-25
Cheracol / USA /
Dosage: unk
Start date: 2010-03-25
Fluticasone Propionate
Dosage: unk
Start date: 2010-03-25
Naproxen
Dosage: unk
Start date: 2010-03-25
Vicodin
Dosage: unk
Start date: 2010-03-25
Possible Nitrofurantoin side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-23
Patient: male
Reactions: Glaucoma, Respiratory Disorder, Hyperbilirubinaemia, Pierre Robin Syndrome, Deafness, Cleft Palate, Body Dysmorphic Disorder, Craniosynostosis, Developmental Delay
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Topamax
Indication: Foetal Exposure During Pregnancy
End date: 2010-11-01
Amoxicillin
Indication: Foetal Exposure During Pregnancy
Flexeril
Indication: Foetal Exposure During Pregnancy
Guaifenesin / Codeine
Indication: Foetal Exposure During Pregnancy
Multi-Vitamins
Indication: Foetal Exposure During Pregnancy
Fluticasone Propionate
Indication: Foetal Exposure During Pregnancy
Ibuprofen
Indication: Foetal Exposure During Pregnancy
Nitrofurantoin
Indication: Foetal Exposure During Pregnancy
Olopatadine HCL
Indication: Foetal Exposure During Pregnancy
Azithromycin
Indication: Foetal Exposure During Pregnancy
Cetirizine HCL
Indication: Foetal Exposure During Pregnancy
Hydrocodone Bitartrate and Acetaminophen
Indication: Foetal Exposure During Pregnancy
Sumatriptan Succinate
Indication: Foetal Exposure During Pregnancy
Naproxen
Indication: Foetal Exposure During Pregnancy
Possible Nitrofurantoin side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-20
Patient: male
Reactions: Respiratory Disorder, Glaucoma, Hyperbilirubinaemia, Deafness, Pierre Robin Syndrome, Craniosynostosis, Body Dysmorphic Disorder, Cleft Palate, Developmental Delay
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Nitrofurantoin
Indication: Foetal Exposure During Pregnancy
Topamax
Indication: Foetal Exposure During Pregnancy
End date: 2010-11-01
Flexeril
Indication: Foetal Exposure During Pregnancy
Multi-Vitamins
Indication: Foetal Exposure During Pregnancy
Possible Nitrofurantoin side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-13
Patient: male
Reactions: Respiratory Disorder, Glaucoma, Hyperbilirubinaemia, Deafness, Pierre Robin Syndrome, Cleft Palate, Craniosynostosis, Body Dysmorphic Disorder, Developmental Delay
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Multi-Vitamins
Indication: Foetal Exposure During Pregnancy
Topamax
Indication: Foetal Exposure During Pregnancy
End date: 2010-11-01
Flexeril
Indication: Foetal Exposure During Pregnancy
Nitrofurantoin
Indication: Foetal Exposure During Pregnancy
Possible Nitrofurantoin side effects in male
Reported by a consumer/non-health professional from United States on 2012-01-04
Patient: male
Reactions: Respiratory Disorder, Hyperbilirubinaemia, Glaucoma, Deafness, Pierre Robin Syndrome, Craniosynostosis, Body Dysmorphic Disorder, Cleft Palate, Developmental Delay
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Flexeril
Indication: Foetal Exposure During Pregnancy
Nitrofurantoin
Indication: Foetal Exposure During Pregnancy
Topamax
Indication: Foetal Exposure During Pregnancy
End date: 2010-11-01
Multi-Vitamins
Indication: Foetal Exposure During Pregnancy
|